You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Tissue Engineered Heart Valve

    SBC: ACELL, INC.            Topic: N/A

    N/A

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  2. A DEVICE FOR REPAIR OF MUCOGINGIVAL TISSUE

    SBC: ACELL, INC.            Topic: N/A

    DESCRIPTION: This research proposes to evaluate the use of urinary bladder-extracellular matrix (UBM-ECM) for the repair of diseased mucogingival tissue. Cells harvested from either attached gingiva or buccal mucosa will be used to seed either of these substrates and the resulting engineered tissue will ultimately be tested for their histogenic potential in ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  3. A Bioscaffold for Repair of Congenital Defects

    SBC: ACELL, INC.            Topic: N/A

    DESCRIPTION (Verbatim from the Applicant's Abstract): This Phase I SBIR application seeks support to develop and evaluate a naturally-occurring extracellular matrix (ECM) bioscaffold material for tissue engineering applications; specifically, the repair and/or restoration of congenital defects in which lost or missing tissue is the limiting factor for s ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. A BIOMATERIAL FOR ESOPHAGEAL REPAIR

    SBC: ACELL, INC.            Topic: N/A

    DESCRIPTION (Unedited Applicant's Abstract):When people with diabetes reach end-stage renal disease they must undergo either dialysis or transplantation. About 200,000 Americans need artificial kidney machines to stay alive. These machines rely on sterile dialysis membranes to remove toxic materials from the bloodstream. More than 30 different polymers or polymer blen ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  5. Antagonists of A2B Receptors Improve Insulin Sensitivity

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    DESCRIPTION (Scanned from the Applicant's Abstract): Blockade of A2B adenosine receptors (A2BARs) increases insulin sensitivity in insulin resistant obese Zucker rats by an effect on skeletal muscle. We have synthesized and characterized the first potent and selective antagonists of A2B receptors. The goal of this phase I SBIR proposal is to develop improved A2 ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  6. ANTAGONIST OF A2B ADENOSINE RECEPTORS FOR ASTHMA

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    DESCRIPTION: (Adapted from the Investigator's Abstract): Adenosine administered as an aerosol to asthmatics causes bronchoconstriction, while in non-asthmatics adenosine causes bronchodilation. This occurs because the activation of A2B adenosine receptors on sensitized mast cells triggers degranulation, releasing histamine, leukotrienes, and other allergic mediators. A2B a ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  7. N/A

    SBC: Adherence Technologies Corp.            Topic: N/A

    The purpose of this research is to develop and test the feasibility of a novel portable computerized system that will enable nursing assistants to provide improved patient care. The system will enable nursing assistants to work more efficiently, record data more accurately, and spend more time with each patient. The system is being designed for use in assisted living facilities and nursing home ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  8. Anti-obesity drug development using human preadipocytes

    SBC: ADIPOGENIX, INC.            Topic: N/A

    N/A

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  9. IRON-SIRR COREGULATION OF S.EPIDERMIDIS VIRULENCE

    SBC: ADVANCED MICROBIAL SOLUTIONS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Iron is an important co-regulator of virulence in many bacterial species including Staphylococcus aurues and Staphylococcus epidermidis both significant human pathogens. The iron dependent transcriptional regulator DtxR [diphtheria toxin repressor] originally identified in Corynebacterium diphtheriae plays a ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  10. Reducing Infection in Indwelling Medical Devices

    SBC: AST PRODUCTS, INC.            Topic: N/A

    DESCRIPTION (Verbatim from the Applicant's Abstract): Urethral catheters are essential in the management of many diseases and conditions yet often result in catheter associated urinary tract infections. The use of sterile closed systems, advanced infection control protocols, and antimicrobial parts has not prevented infection or the associated morbidity increase. Ad ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government